产品编号：K202057
产品规格：5mg
产品价格：面议
| 标准品编号: | K202057 |
| 名称: | 15-Keto Prostaglandin E0-d4 |
| 别名: | (11α)-11-Hydroxy-9,15-dioxo-prostan-1-oic Acid-d4; 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid-d4; 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid Stereoisomer-d4; 11α-Hydroxy-9,15-diketoprostanoic Acid-d4; 11α-Hydroxy-9,15-dioxoprostanoic Acid-d4; 13,14-Dihydro-15-keto-PGE1-d4; 13,14-Dihydro-15-keto-PGE1-d4; 13,14-Dihydro-15-ketoprostaglandin E1-d4; 13,14-Dihydro-15-oxo-PGE1-d4; 15-Oxodihydroprostaglandin E1-d4; 15-keto-13,14-Dihydro-PGE1-d4; 15-keto-13,14-Dihydroprostaglandin E1-d4; Dihydro-15-ketoprostaglandin E1-d4; U 21002-d4 |
| 参考CAS号: | Unlabelled: 5094-14-4 |
| 分子式: | C₂₀H₃₀D₄O₅ |
| 分子量: | 358.51 |
| 种类: | Building Blocks; Isotopic Labeled Analogues; |
| 应用: | 15-Keto Prostaglandin E0-d4 is the isotope labelled analog of 15-Keto Prostaglandin E0 (K202055); a metabolite of Prostaglandin E1 (P838600) that has been shown to induce arterial thromboresistance in experimental animals and in man, but with several magnitudes higher concentrations than Prostaglandin E1. 15-Keto Prostaglandin E0 is also used as the active ingredient in compositions used for the treatment of external secretion disorders. |
| 参考文献 | |
